Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 10 | 2015 | 1103 | 1.240 |
Why?
|
| Marijuana Use | 3 | 2025 | 222 | 1.230 |
Why?
|
| Gray Matter | 4 | 2019 | 92 | 1.190 |
Why?
|
| Alcoholism | 7 | 2018 | 826 | 1.060 |
Why?
|
| Risk-Taking | 10 | 2018 | 323 | 1.020 |
Why?
|
| Executive Function | 6 | 2021 | 470 | 0.970 |
Why?
|
| Cannabis | 2 | 2025 | 510 | 0.970 |
Why?
|
| Adolescent Behavior | 8 | 2019 | 497 | 0.960 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2019 | 3916 | 0.950 |
Why?
|
| Brain | 12 | 2019 | 2969 | 0.830 |
Why?
|
| Neuroimaging | 2 | 2017 | 300 | 0.750 |
Why?
|
| Alcohol Drinking | 7 | 2019 | 843 | 0.730 |
Why?
|
| Cognition | 3 | 2025 | 1271 | 0.670 |
Why?
|
| Sexual Behavior | 5 | 2018 | 495 | 0.650 |
Why?
|
| Reward | 4 | 2018 | 248 | 0.650 |
Why?
|
| Marijuana Smoking | 4 | 2019 | 249 | 0.640 |
Why?
|
| White Matter | 2 | 2019 | 155 | 0.600 |
Why?
|
| Tobacco Use | 1 | 2019 | 62 | 0.570 |
Why?
|
| Parietal Lobe | 2 | 2015 | 61 | 0.530 |
Why?
|
| Marijuana Abuse | 2 | 2017 | 214 | 0.500 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 468 | 0.500 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 474 | 0.470 |
Why?
|
| Alcohol-Related Disorders | 2 | 2013 | 121 | 0.450 |
Why?
|
| Temporal Lobe | 1 | 2015 | 107 | 0.440 |
Why?
|
| Craving | 1 | 2015 | 40 | 0.430 |
Why?
|
| Psychotherapy | 1 | 2015 | 182 | 0.400 |
Why?
|
| Telemedicine | 1 | 2023 | 967 | 0.400 |
Why?
|
| Juvenile Delinquency | 1 | 2013 | 94 | 0.380 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2014 | 168 | 0.340 |
Why?
|
| Sex Characteristics | 2 | 2016 | 789 | 0.330 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 185 | 0.330 |
Why?
|
| Adolescent | 22 | 2019 | 22577 | 0.330 |
Why?
|
| Organ Size | 3 | 2017 | 461 | 0.310 |
Why?
|
| Text Messaging | 1 | 2012 | 182 | 0.290 |
Why?
|
| Self Report | 3 | 2013 | 876 | 0.290 |
Why?
|
| Aging | 3 | 2016 | 1973 | 0.280 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2013 | 47 | 0.270 |
Why?
|
| Humans | 33 | 2025 | 145783 | 0.230 |
Why?
|
| Limbic System | 2 | 2018 | 55 | 0.220 |
Why?
|
| Adolescent Development | 2 | 2018 | 72 | 0.220 |
Why?
|
| Pilot Projects | 2 | 2021 | 1898 | 0.210 |
Why?
|
| Male | 25 | 2019 | 73011 | 0.200 |
Why?
|
| Female | 25 | 2019 | 79045 | 0.190 |
Why?
|
| Nerve Net | 2 | 2018 | 286 | 0.180 |
Why?
|
| Young Adult | 14 | 2018 | 14254 | 0.170 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2013 | 78 | 0.160 |
Why?
|
| Condoms | 3 | 2018 | 102 | 0.160 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 336 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2021 | 197 | 0.160 |
Why?
|
| Longitudinal Studies | 5 | 2014 | 2968 | 0.150 |
Why?
|
| Underage Drinking | 1 | 2019 | 22 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 269 | 0.140 |
Why?
|
| Puberty | 2 | 2018 | 137 | 0.140 |
Why?
|
| Brain Mapping | 3 | 2018 | 542 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2023 | 1115 | 0.140 |
Why?
|
| Safe Sex | 1 | 2018 | 24 | 0.140 |
Why?
|
| Delay Discounting | 1 | 2018 | 29 | 0.130 |
Why?
|
| Functional Neuroimaging | 2 | 2015 | 61 | 0.130 |
Why?
|
| Southwestern United States | 1 | 2017 | 93 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2018 | 93 | 0.130 |
Why?
|
| Aged | 3 | 2023 | 26217 | 0.120 |
Why?
|
| Corpus Striatum | 1 | 2018 | 179 | 0.120 |
Why?
|
| Anisotropy | 2 | 2013 | 74 | 0.120 |
Why?
|
| Linear Models | 2 | 2016 | 849 | 0.120 |
Why?
|
| Cognitive Neuroscience | 1 | 2016 | 9 | 0.120 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 6085 | 0.110 |
Why?
|
| Cues | 2 | 2018 | 329 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 276 | 0.110 |
Why?
|
| Middle Aged | 8 | 2019 | 36309 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 97 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 783 | 0.100 |
Why?
|
| Drug Users | 1 | 2014 | 43 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 198 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2012 | 156 | 0.100 |
Why?
|
| Cerebrum | 1 | 2013 | 7 | 0.100 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 29 | 0.100 |
Why?
|
| Taste Perception | 1 | 2013 | 31 | 0.100 |
Why?
|
| Sex Factors | 1 | 2019 | 2110 | 0.100 |
Why?
|
| Self-Evaluation Programs | 1 | 2012 | 5 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2013 | 501 | 0.090 |
Why?
|
| Binge Drinking | 1 | 2012 | 45 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2015 | 413 | 0.090 |
Why?
|
| Intention | 1 | 2013 | 186 | 0.090 |
Why?
|
| Self-Assessment | 1 | 2012 | 74 | 0.080 |
Why?
|
| Radiography | 1 | 2014 | 853 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 5925 | 0.080 |
Why?
|
| Cerebellum | 1 | 2012 | 224 | 0.080 |
Why?
|
| Adult | 8 | 2018 | 40881 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2012 | 317 | 0.080 |
Why?
|
| Ethanol | 1 | 2012 | 631 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2933 | 0.070 |
Why?
|
| Smoking | 1 | 2015 | 1477 | 0.070 |
Why?
|
| Risk Factors | 4 | 2013 | 10919 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 8347 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 5428 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2013 | 11794 | 0.040 |
Why?
|
| Exercise | 1 | 2013 | 2205 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2018 | 690 | 0.040 |
Why?
|
| HIV Infections | 1 | 2016 | 3195 | 0.040 |
Why?
|
| Decision Making | 2 | 2018 | 982 | 0.040 |
Why?
|
| Methylation | 1 | 2017 | 242 | 0.030 |
Why?
|
| Unsafe Sex | 1 | 2016 | 61 | 0.030 |
Why?
|
| Taste | 1 | 2018 | 238 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 428 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2014 | 130 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 171 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1247 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 38102 | 0.020 |
Why?
|
| Neuroanatomy | 1 | 2012 | 10 | 0.020 |
Why?
|
| Neuropsychology | 1 | 2012 | 44 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 160 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 30 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 390 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 2028 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1300 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 368 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 3346 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 1137 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2015 | 17330 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 3170 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 1420 | 0.010 |
Why?
|
| Mental Health | 1 | 2010 | 796 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 7134 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 8078 | 0.010 |
Why?
|
| United States | 1 | 2013 | 16126 | 0.010 |
Why?
|
| Child | 1 | 2010 | 22740 | 0.010 |
Why?
|